Associations - APC (APC Regulator Of WNT Signaling Pathway)

APC mutation + BRCA2 mutation	Colorectal Cancer	APC mutation + BRCA2 mutation	Colorectal Cancer	mFOLFOX6 Sensitive: C3 – Early Trials mFOLFOX6 Sensitive : C3	mFOLFOX6 Sensitive: C3 – Early Trials mFOLFOX6 Sensitive : C3
APC mutation	Hormone Receptor Positive Breast Cancer	APC mutation	Hormone Receptor Positive Breast Cancer	lenvatinib Resistant: C3 – Early Trials lenvatinib Resistant : C3	lenvatinib Resistant: C3 – Early Trials lenvatinib Resistant : C3
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
APC mutation	Gastrointestinal Stromal Tumor	APC mutation	Gastrointestinal Stromal Tumor	dasatinib Sensitive: C3 – Early Trials dasatinib Sensitive : C3	dasatinib Sensitive: C3 – Early Trials dasatinib Sensitive : C3
APC mutation + KRAS mutation	Colorectal Cancer	APC mutation + KRAS mutation	Colorectal Cancer	mFOLFOX6 Sensitive: C3 – Early Trials mFOLFOX6 Sensitive : C3	mFOLFOX6 Sensitive: C3 – Early Trials mFOLFOX6 Sensitive : C3
APC mutation	Colon Cancer	APC mutation	Colon Cancer	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3	Immunotherapy Resistant: C3 – Early Trials Immunotherapy Resistant : C3
HER-2 positive + APC mutation	Gastric Cancer	HER-2 positive + APC mutation	Gastric Cancer	nivolumab + trastuzumab Resistant: C3 – Early Trials nivolumab + trastuzumab Resistant : C3	nivolumab + trastuzumab Resistant: C3 – Early Trials nivolumab + trastuzumab Resistant : C3
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3
APC V2194fs + EGFR amplification + EGFR-SEPTIN14 fusion	Gastric Cancer	APC V2194fs + EGFR amplification + EGFR-SEPTIN14 fusion	Gastric Cancer	nivolumab Resistant: C4 – Case Studies nivolumab Resistant : C4	nivolumab Resistant: C4 – Case Studies nivolumab Resistant : C4
KRAS G12V + TP53 mutation + APC mutation	Pancreatic Adenocarcinoma	KRAS G12V + TP53 mutation + APC mutation	Pancreatic Adenocarcinoma	trametinib Sensitive: C4 – Case Studies trametinib Sensitive : C4	trametinib Sensitive: C4 – Case Studies trametinib Sensitive : C4
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	G007-LK Sensitive: D – Preclinical G007-LK Sensitive : D	G007-LK Sensitive: D – Preclinical G007-LK Sensitive : D
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	FL118 Sensitive: D – Preclinical FL118 Sensitive : D	FL118 Sensitive: D – Preclinical FL118 Sensitive : D

APC (APC Regulator Of WNT Signaling Pathway)

Associations(15)

Associations
(15)